321 related articles for article (PubMed ID: 3871207)
21. An approach for studies of mediator-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery.
Yamaki K; Lindbom L; Thorlacius H; Hedqvist P; Raud J
Br J Pharmacol; 1998 Feb; 123(3):381-9. PubMed ID: 9504377
[TBL] [Abstract][Full Text] [Related]
22. Immune-complex-induced inflammatory reaction studied by intravital microscopy: role of histamine and arachidonic acid metabolites.
Björk J; Smedegård G
Inflammation; 1987 Mar; 11(1):47-58. PubMed ID: 2883121
[TBL] [Abstract][Full Text] [Related]
23. Novel neuropeptide Y receptor antagonists block vasoconstriction in the hamster cheek pouch microcirculation.
Kim D; Durán WT; Daniels AJ; Durán WN
Microvasc Res; 1997 Mar; 53(2):167-72. PubMed ID: 9143549
[TBL] [Abstract][Full Text] [Related]
24. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
25. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
Fernandez HN; Hugli TE
J Immunol; 1976 Nov; 117(5 Pt 1):1688-94. PubMed ID: 1002996
[TBL] [Abstract][Full Text] [Related]
26. Anaphylatoxin-mediated regulation of human and murine immune responses.
Morgan EL; Weigle WO; Hugli TE
Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
[TBL] [Abstract][Full Text] [Related]
27. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
28. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
29. Possible mechanisms for the inhibitory effect of Ruscus extract on increased microvascular permeability induced by histamine in hamster cheek pouch.
Bouskela E; Cyrino FZ; Marcelon G
J Cardiovasc Pharmacol; 1994 Aug; 24(2):281-5. PubMed ID: 7526061
[TBL] [Abstract][Full Text] [Related]
30. The role of C3a in pulmonary alveoli following trauma.
Obertacke U; Joka T; Zilow G; Kirschfink M; Schmit-Neuerburg KP
Prog Clin Biol Res; 1989; 308():43-9. PubMed ID: 2789395
[No Abstract] [Full Text] [Related]
31. Anaphylatoxins: possible roles in disease.
Vogt W
Complement; 1986; 3(3):177-88. PubMed ID: 3026724
[TBL] [Abstract][Full Text] [Related]
32. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
33. Structure and function of the anaphylatoxins.
Hugli TE
Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
[TBL] [Abstract][Full Text] [Related]
34. Microvascular effects of iloprost in the hamster cheek pouch.
Müller B; Schmidtke M
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():455-8. PubMed ID: 2444080
[TBL] [Abstract][Full Text] [Related]
35. Vascular permeability changes induced by complement-derived peptides.
Williams TJ
Agents Actions; 1983 Aug; 13(5-6):451-5. PubMed ID: 6195896
[TBL] [Abstract][Full Text] [Related]
36. Longchain n-3 polyunsaturated fatty acids and microvascular reactivity: observation in the hamster cheek pouch.
Conde CM; Cyrino FZ; Bottino DA; Gardette J; Bouskela E
Microvasc Res; 2007 May; 73(3):237-47. PubMed ID: 17196224
[TBL] [Abstract][Full Text] [Related]
37. Dimensions of postcapillary venules sensitive to bradykinin and histamine-induced leakage of macromolecules.
Svensjö E; Arfors KE
Ups J Med Sci; 1979; 84(1):47-60. PubMed ID: 442278
[TBL] [Abstract][Full Text] [Related]
38. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
Nagata S; Glovsky MM; Kunkel SL
Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
[TBL] [Abstract][Full Text] [Related]
39. Contribution of complement factors and reaction pathways to inflammation.
Bitter-Suermann D
Agents Actions Suppl; 1982; 11():159-78. PubMed ID: 6758550
[No Abstract] [Full Text] [Related]
40. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
